Results from the US Food and Drug Administration’s and manufacturers’ responses this year to an infant formula shortage pointed the agency to plan to streamline its procedures for allowing additional firms to market formula.
The agency on 6 July announced it has “determined that a more streamlined pathway” using information it has received for...